Response to letter regarding article, humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity (IEI) or mannan-binding lectin (MBL) deficiency—A prospective controlled open-label trial: correspondence
本文未提供摘要，请点击“查看全文”查看完整内容。